Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study) (Q90190621)
Jump to navigation
Jump to search
scientific article published on 20 September 2019
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study) |
scientific article published on 20 September 2019 |
Statements
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study) (English)
Catherine Orrell
Stephen Walimbwa
Yashna Singh
Kenneth Kintu
Bryony Simmons
Mary Sihlangu
Thoko Malaba
Alieu Amara
Joshua Gini
Laura Else
Christie Heiburg
Andrew Hill
Mohammed Lamorde
20 September 2019
20 September 2019
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference